The PCM1 gene homepage

General information
Gene symbol PCM1
Gene name pericentriolar material 1
Chromosome 8
Chromosomal band p22-p21.3
Imprinted Unknown
Genomic reference NG_027690.1
Transcript reference NM_006197.3, XM_005273509.1, XM_005273510.1, XM_005273511.1, XM_005273512.1, XM_005273513.1, XM_005273514.1, XM_005273515.1, XM_005273516.1, XM_005273517.1, XM_005273518.1, XM_005273519.1, XM_005273520.1, XM_005273521.1, XM_005273522.1, XM_005273523.1, XM_005273524.1
Associated with diseases NMTC-1
Citation reference(s) -
Curators (1) Johan T. den Dunnen
Total number of public variants reported 351
Unique public DNA variants reported 41
Individuals with public variants 35
Hidden variants 409
Date created October 30, 2013
Date last updated September 28, 2016
Version PCM1:160928

Graphical displays and utilities
Graphs Graphs displaying summary information of all variants in the database »
UCSC Genome Browser Show variants in the UCSC Genome Browser (full view, compact view)
Ensembl Genome Browser Show variants in the Ensembl Genome Browser (full view, compact view)
NCBI Sequence Viewer Show distribution histogram of variants in the NCBI Sequence Viewer

Links to other resources
External URL List of LSDBs for this gene
The reference LOVD for this gene, if available
HGNC HGNC:8727
Entrez Gene 5108
PubMed articles PCM1
OMIM - Gene 600299
OMIM - Diseases NMTC-1 (cancer, thyroid, nonmedullary, type 1 (NMTC-1, papillary thyroid carcinoma))
HGMD PCM1
GeneCards PCM1
GeneTests PCM1


Active transcripts


ID     

Chr     

Name     

NCBI ID     

NCBI Protein ID     

DescendingVariants     
00005616 8 pericentriolar material 1 NM_006197.3 NP_006188.3 351
00047051 8 transcript variant X2 XM_005273510.1 - -
00047052 8 transcript variant X10 XM_005273518.1 XP_005273575.1 -
00047053 8 transcript variant X13 XM_005273521.1 XP_005273578.1 -
00047054 8 transcript variant X12 XM_005273520.1 XP_005273577.1 -
00047055 8 transcript variant X8 XM_005273516.1 XP_005273573.1 -
00047056 8 transcript variant X6 XM_005273514.1 XP_005273571.1 -
00047057 8 transcript variant X16 XM_005273524.1 XP_005273581.1 -
00047058 8 transcript variant X7 XM_005273515.1 XP_005273572.1 -
00047059 8 transcript variant X11 XM_005273519.1 XP_005273576.1 -
00047060 8 transcript variant X14 XM_005273522.1 XP_005273579.1 -
00047061 8 transcript variant X3 XM_005273511.1 - -
00047062 8 transcript variant X1 XM_005273509.1 XP_005273566.1 -
00047063 8 transcript variant X9 XM_005273517.1 XP_005273574.1 -
00047064 8 transcript variant X4 XM_005273512.1 XP_005273569.1 -
00047065 8 transcript variant X5 XM_005273513.1 XP_005273570.1 -
00047066 8 transcript variant X15 XM_005273523.1 XP_005273580.1 -


Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective submitter(s) and curator(s) of the individual records. Individual data entries may indicate which data license applies to that specific record. When no license is listed, no permissions are granted. Any unauthorized use, copying, storage, or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2013-2025. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising from any inaccuracies or omissions. Individuals, organizations, and companies that use this database do so on the understanding that no liability whatsoever, either direct or indirect, shall rest upon the data submitter(s), curator(s), or any of their employees or agents for the effects of any product, process, or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.